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a b s t r a c t
Objective: Protein-pacing (P; 5–6 meals/day @ 2.0 g/kg BW/day) and multi-mode exercise (RISE; resistance, interval, stretching, endurance) training (PRISE) improves muscular endurance, strength, power and arterial health
in exercise-trained women. The current study extends these ﬁndings by examining PRISE on ﬁtness, growth hormone (GH), insulin-like growth factor-1 (IGF-1), and brain-derived neurotrophic factor (BDNF) response, cardiometabolic health, and body composition in exercise-trained men.
Design: Twenty active males (N4 days exercise/week) completed either: PRISE (n = 11) or RISE (5–6 meals/day
@ 1.0 g/kg BW/day; n = 9) for 12 weeks. Muscular strength (1-repetition maximum bench and leg press, 1-RM
BP, and 1-RM LP), endurance (sit-ups, SU; push-ups, PU), power (squat jump, SJ, and bench throw, BT), ﬂexibility
(sit-and-reach, SR), aerobic performance (5 km cycling time-trial, TT), GH, IGF-1, BDNF, augmentation index,
(AIx), and body composition, were assessed at weeks 0 (pre) and 13 (post).
Results: At baseline, no differences existed between groups except for GH (RISE, 230 ± 13 vs. PRISE, 382 ± 59 pg/
ml, p b 0.05). The exercise intervention improved 1-RM, SJ, BT, PU, SU, SR, 5 km-TT, GH, AIx, BP, and body composition in both groups (time, p b 0.05). However, PRISE elicited greater improvements in 1-RM BP (21 vs.
10 Δlbs), SJ (171 vs. 13 ΔW), 5 km-TT (−37 vs. −11 Δs), and sit-and-reach (5.3 vs. 1.2 Δcm) over RISE alone
(p b 0.05) including increased IGF-1 (12%, p b 0.05).
Conclusions: Exercise-trained men consuming a P diet combined with multi-component exercise training (PRISE)
enhance muscular power, strength, aerobic performance, and ﬂexibility which are not likely related to GH or
BDNF but possibly to IGF-1 response.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).

1. Introduction
The use of protein supplementation is commonly used to enhance
muscle recovery and/or improve satiety. Recently, we demonstrated
that a protein-pacing diet alone (P; 5–6 meals/day @ N 1.4 g/kg body
weight (BW) protein/day) [1] and when combined with a multi-mode
(RISE; resistance, interval, stretching, endurance) exercise intervention
(PRISE) results in greater reductions in total and regional (abdominal/
visceral) fat mass, greater gains in lean mass, and enhanced cardiometabolic health compared to a combined protein-pacing and traditional
resistance training intervention in obese/overweight women [2]. Following on this work, we recruited healthy, normal weight, exercise-

☆ This study was registered with ClinicalTrials.gov Identiﬁer: NCT02593656.
⁎ Corresponding author at: Human Nutrition & Metabolism Laboratory, Health and
Exercise Sciences Department, Skidmore College, 815 N. Broadway, Saratoga Springs, NY
12866, United States.
E-mail address: parciero@skidmore.edu (P.J. Arciero).

trained women who were randomized to either a control (1.0 g/kg
BW protein/day) or protein-pacing group (2.0 g/kg BW protein/day),
and both groups completed 12 weeks of RISE exercise training [3].
Women consuming the protein-pacing diet (PRISE, 2.0 g/kg BW protein/day) exhibited signiﬁcantly greater gains in muscular strength, endurance, power, and improvements in markers of cardiovascular health
[3] compared to the RISE only (1.0 g/kg BW protein/day) intervention.
Thus, in exercise-trained healthy, normal weight women, proteinpacing improves the adaptations to multi-modal exercise training.
Indeed, the majority of studies investigating the potential physical or
performance beneﬁt of protein supplementation have focused on men,
speciﬁcally in acute and/or mono-modal exercise paradigms (e.g. resistance training or running), which have shown protein ingestion improves muscle recovery [4,5], enhances improvements in muscle mass
[6] and/or exercise performance [7–9]. However, the most recent recommendations by the American College of Sports Medicine, suggest a
comprehensive approach to exercise training, by including not only endurance exercise, but also resistance, ﬂexibility, and neuro-motor

http://dx.doi.org/10.1016/j.ghir.2016.10.002
1096-6374/© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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training [10]. Taken together with the progression of the ﬁtness ﬁeld towards a more multi-modal paradigm, understanding the potential beneﬁt of elevated protein intake in this context is paramount. Additionally,
while protein-pacing has been demonstrated to increase muscle protein
synthesis [11,12], the purported mechanisms responsible for the enhanced response to multi-modal training with elevated protein intake,
such as enhanced anabolic hormonal milieu (i.e. growth factors), remain relatively unexplored.
It is well recognized that growth factors such as growth hormone
(GH), insulin-like growth factor-1 (IGF-1), and brain derived neurotrophic factor (BDNF) and their receptors are key regulators of neuromuscular development [13]. Indeed, recent work has found that both
acute and chronic exercise increases anterior pituitary activity and GH
release, suggestive of a prominent role of the endocrine system in muscular adaptations [14]. However, recent work has suggested that circulating levels of growth factors might not reﬂect functional changes in
muscle (i.e. strength) [15], perhaps depending more upon neurological
development [16] or the biological compartment being explored [17].
As much of the previous work has focused on the response to monomodal resistance exercise training, coupled with mounting controversy
over whether circulating hormones reﬂect functional changes (i.e.
strength, power, etc.), further work is needed to determine if circulating
anabolic factors might explain the adaptations to training.
Accordingly, the primary aim of the present study was to compare
the response to the multi-modal RISE training in healthy active men
consuming either a normal protein (RISE, control group) intake versus
a higher protein intake (PRISE) on ﬁtness-related performance, cardiovascular, metabolic, and hunger/satiety outcomes, as well as blood
levels of GH, IGF-1, and BDNF. We hypothesized that 1.) RISE would improve ﬁtness, cardiovascular health, metabolic markers, and hunger/satiety, and 2.) Such improvements would be enhanced in the protein
supplemented (PRISE) group, perhaps mediated by greater anabolic signaling, as measured by GH, IGF-1, and BDNF.
2. Methods
2.1. Participants
A total of 63 men from the Saratoga Springs, NY area, responded to
emails, ﬂyers and local newspapers to advertisements and were initially
screened, of which 30 were eligible for participation (Fig. 1). Participants were nonsmoking, healthy, physically active men with no
known cardiovascular or metabolic diseases as assessed by a medical
history and a comprehensive medical examination. Speciﬁcally, all participants were highly active (minimum of N 30 min, 4 day/week of structured physical activity), normal weight (BMI b 25 kg/m2; % body
fat ≤ 30%), middle aged (25–55 years), and weight stable (±2 kg) for
at least 6 months prior to the beginning of the study. All participants
provided informed written consent prior to participation, and the
study was approved by the Institutional Review Board of Skidmore College (IRB#: 1401-382). All experimental procedures were performed in
accordance with the Federal Wide Assurance and related New York
State regulations, which are consistent with the National Commission
for the Protection of Human Subjects of Biomedical and Behavioral Research and in agreement with the Helsinki Declaration as revised in
1983. This study was registered with ClinicalTrials.gov Identiﬁer:
NCT02593656.
2.2. Experimental design
2.2.1. Study timeline
Participants were randomly assigned to one of two groups: (1) protein pacing and multi-mode exercise training (PRISE; n = 12; 5–6
meals/day @ 2.0 g/kg BW/day) or (2) normal protein and multi-mode
exercise training (RISE; n = 14; 5–6 meals/day @ 1.0 g/kg BW/day).
All participants performed the same RISE exercise training program
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Fig. 1. Subject recruitment, enrollment, and assignment procedures.

consisting of 4 days/week of closely supervised and monitored progressive exercise training for 12 weeks (see previous references [2,3]). All
testing procedures (see below) were administered pre-intervention
(week 0) and post intervention (week 13) unless noted otherwise.
Upon arrival at the laboratory, anthropometric and body composition
measurements and blood sampling for subsequent analysis were
performed.

2.3. Nutrition intervention
Meal plans were identically matched in terms of total kcals, meal frequency and timing and dietary support. By design, the only differences
between the two groups was the amount of protein (1.0 vs. 2.0 g/kg
BW per day). Additional supplementation (daily multi-vitamin/
minerals, and caffeine and electrolytes on workout days) was also provided to participants and differed only by the type of product manufacturer. Participants in both groups were provided detailed meal plans
designed by a registered dietitian and instructed to follow the meal
plans throughout the 12-week intervention (Table A1). The registered
dietitian met with participants weekly for the ﬁrst two weeks and
thereafter on an “as needed” basis. In addition, investigators met with
participants a minimum of 4 day/week to answer questions and reinforce compliance to meal plans. To facilitate adherence to the meal
plans, food was provided to both groups. It's important to note that
the protein dosing was equivalent to N0.25 g/kg BW per meal which
has been shown to be the optimal intake for muscle protein synthesis
[18]. By study design, the only macronutrient that was intentionally different between groups was the protein per kg BW. Participants in both
groups were given a 1-week. supply of the supplements and asked to return empty packets before they received the next week's supply as a
means of assessing their compliance. Both groups were provided equivalent nutritional support and similar caloric intakes throughout the
12 week intervention.
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The timing of meals was an important component of the current
study and both groups consumed meals using an identical meal pattern
schedule. On resistance and interval exercise days (see below), participants consumed a small snack (~ 250 kcals) prior and on stretching
and endurance days arrived a minimum of 2–3 h fasted but wellhydrated and were allowed to consume the electrolyte beverage as
needed on all exercise days. Breakfast was consumed after the exercise
and remaining meals were consumed at 3 h intervals throughout the remainder of the day. On non-exercise days, participants consumed
breakfast within an hour of waking in the morning and remaining
meals at 3 h intervals thereafter (Table A1).
2.4. RISE exercise training protocol
Subjects in both groups underwent the same closely supervised/
monitored progressive multiple exercise training regimen as described
previously [2]. Brieﬂy, the training program consisted of four speciﬁc
types of exercise training: 1) resistance exercise; 2) interval sprints;
3) stretching/yoga/pilates, and 4) endurance exercise (RISE training,
[2,3]. Subjects underwent four exercise sessions per week and the sessions rotated through the four types of exercise, such that each of the
four exercises were performed 1 day per week. To familiarize participants with the individual exercises and to ensure compliance, all training sessions were performed in the Skidmore College Sports Center
under the close supervision of the research team. Intensity level was
monitored at every exercise sessions with heart rate monitors (Polar
H7, Polar Electro, Lake Success, NY, USA) to ensure subject safety and
proper compliance with the exercise program.
Speciﬁc details of the 4 types of exercises that comprise the RISE
training have been previously published [2,19]. Brieﬂy, the resistance
training sessions were completed within 60 min and consisted of a dynamic warm-up, footwork and agility, lower and upper body resistance,
and core exercises all performed at a resistance to induce muscular fatigue in 10–15 repetitions and for 2–3 sets. A 30-s recovery was provided between sets and a 60-s recovery was allowed between different
exercises. The sprint interval training sessions were completed within
35 min and consisted of either 7 sets of 30-s “all-out” with 4 min recovery or 10 sets of 60-s “almost all-out” with 2 min of rest after each interval. Participants were allowed to perform the sprints using any mode of
exercise. The stretching routine incorporated traditional yoga poses
with additional stretches and Pilates movements providing a total
body stretching, ﬂexibility and strengthening workout. All sessions
were completed within 60 min and were led by a certiﬁed yoga instructor. Finally, endurance exercise training was performed for 60 min at a
moderate pace (60% of maximal effort). Participants were allowed to
choose from a variety of aerobic activities, including running, cycling,
rowing, swimming, etc.

1.10.0.1, TensioMed Kft., Budapest, Hungary). Augmentation index
was determined by the following formula:
AIxð%Þ ¼ ðP2−P1Þ=PP  100
where P1 is the early (direct) wave's amplitude; P2 is the late (reﬂected)
systolic wave's amplitude; and PP equals the pulse pressure.
The aortic pulse wave velocity (PWVao) was determined by the
wave reﬂection generated from the early direct pulse wave as it is
reﬂected back from the aortic bifurcation. Return time (RT) is determined by measuring the time interval between peaks from the early direct (P1) and reﬂected late (P2) systolic waves. The PWVao calculations
were measured using the distance from the upper edge of the pubic
bone to the sternal notch (Jugulum-Symphisis1/4), as this provides
the closest approximation of the actual aortic length. PWVao was calculated with the following formula:
PWVaoðm=sÞ ¼ ½Jug‐SyðmÞ=½ðRT=2ÞðsÞ
where, RT is return time; Jug-Sy is the aortic distance (JugulumSymphisis).
2.7. Blood assays
2.7.1. Blood lipids and C-reactive protein
A 12-hour fasted venous blood sample (~ 20 ml) was obtained at
baseline (week 0) and post-intervention (weeks 13). Blood was collected into EDTA-coated vacutainer tubes and centrifuged (Hettich Rotina
46R5) for 15 min at 2500 rpm at 4 °C. Upon separation, plasma was
stored at −80 °C in aliquots until analyzed. Plasma C-reactive protein
and insulin concentrations were determined using commercially available ELISA kits (Millipore, Billerica MA). Total cholesterol (TC), highdensity lipoprotein cholesterol (HDL-C), and triglycerides (TRG) were
assessed using the Cholestech LDX blood analysis system (Hayward,
CA). Test-retest intraclass correlation (r) and coefﬁcient of variation
(CV) in our laboratory with n = 15 is: TC, and HDL-C (mg/dl) r =
0.95, CV = 3.2%, and r = 0.97, CV = 5.3%, respectively.
2.7.2. Growth hormone, BDNF, and IGF-1
Growth hormone (GH), brain derived neurotrophic factor (BDNF),
and insulin-like growth factor-1 (IGF-1) concentrations were determined using commercially available ELISA kits (R&D Systems, Minneapolis, MN). The intra- and inter-assay coefﬁcient of variation (CV) is 3.1,
and 8.0%, respectively for GH. The intra- and inter-assay coefﬁcient of
variation (CV) is 5.0, and 9.0%, respectively for BDNF. The intra- and
inter-assay coefﬁcient of variation (CV) is 4.0, and 8.0%, respectively
for IGF-1.The linearity was r2 = 0.997, r2 = 1.000, and r2 = 0.995 for
GH, BDNF, and IGF-1, respectively.

2.5. Laboratory testing procedures
2.8. Resting metabolic rate (RMR)
All testing was performed between 0600 and 0900, following a 12-h
fast and 48-h abstinence from caffeine and alcohol intake, and 48–72 h
after the last exercise session to eliminate the acute effects of the last
bout of exercise. These tests were performed at week 0 and 13.
2.6. Cardiovascular health
2.6.1. Heart rate and blood pressure
Resting heart rate and systolic and diastolic blood pressure (BP)
were obtained in the supine position as previously described [2].
Heart rate and BP were obtained following a minimum of 10 min of
quiet resting.
2.6.2. Vascular function
Vascular function was assessed using pulse contour analysis (augmentation index) and pulse wave velocity (Arteriograph, version

Resting metabolic rate (RMR; kcal/min) was measured via indirect
calorimetry at weeks 0 and 13 using the ventilated hood technique
(ParvoMedic; analyzed via True One software, Salt Lake City UT). Participants arrived at the Human Nutrition and Metabolism Laboratory immediately upon waking (between 0600 and 0800). Following 20 min
of quiet lying, REE was measured for 30 min while subjects lay supine
in a darkened, temperature controlled room. Test-retest intraclass correlation (r) and coefﬁcient of variation (CV) in our laboratory with
n = 14 is: RMR r = 0.92, 4.2%, respectively.
2.9. Total and regional body composition
Anthropometric measurements were obtained at baseline and 13
weeks. Body weight was obtained during each visit with a standard digital scale. Height was measured without shoes using a stadiometer.
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Waist circumferences were obtained in centimeters with a standard
tape measure. Waist measurement was obtained at the area with the
smallest circumference between the rib cage and the iliac crest. Body
Composition was assessed by Dual Energy X-ray Absorptiometry
(iDXA; Lunar iDXA; GE Healthcare, Madison, WI; analyzed using encore
software version 13.6). Total body adiposity, % body fat, lean body mass,
visceral adipose tissue (VAT), and regional abdominal adiposity were all
analyzed from iDXA scans as previously described [2]. Test-retest
intraclass correlation (r) and coefﬁcient of variation (CV) for body composition analysis using iDXA in our laboratory with n = 12 is: LBM and
FM r = 0.99, CV = 0.64%, and r = 0.98, CV = 2.2% respectively and for
regional abdominal body composition analysis is: %fat r = 0.99, CV =
2.4%.
2.10. Dietary intake and feelings of hunger and satiety
Throughout the intervention, subjects maintained a daily food log
that included all food and beverages consumed each day, including
meal timing. To further verify compliance, food intake was analyzed
from a representative 3-day period at weeks 0 and 12 using Food Processor SQL Edition (version 10.12.0, 2012; ESHA Research, Salem, OR)
as previously described [2]. All dietary analyses were performed by
the same technician. Visual analog scales (VAS) were administered at
baseline and week 13 to evaluate the effects of the lifestyle interventions on hunger, satiation, and desire-to-eat [2].
2.11. Physical performance assessments
Physical performance outcomes were assessed at weeks 0 and 13.
Following a familiarization session of all testing procedures, physical
performance measures were obtained at the same time of day and completed over a two day period. For example, aerobic power (5 km TT),
muscular endurance (sit-ups/push-ups), ﬂexibility (sit and reach), and
balance (standing stork balance) were completed on day one, whereas,
upper and lower body strength (bench press/leg press) and power tests
(squat jumps/bench throws) and vertical jump were completed on day
two (see below).
2.11.1. Upper body muscular endurance
Upper body muscular endurance was assessed with timed push-ups
in 1 min. Women started in the plank position balancing on the knees
with arms extended and hands placed under the shoulders. A successful
push-up was deﬁned as lowering the body so elbows reached 90°
followed by a return to the starting plank position. Participants were
asked to perform as many push-ups as possible within 60 s in a continuous pattern with no more than 2 s of rest between repetitions.
2.11.2. Core muscular endurance
Timed sit-ups were performed in the supine position with arms
folded across the chest, knees bent at 90° and feet ﬂat on the ground
and supported by a research team member. A successful sit-up required
participants to curl up to a 90° position (vertical) to the ﬂoor and then
return to the starting position. The sit-up action was continuous, with
a rest duration of no N2 s allowed between repetitions. Participants
were instructed to perform as many sit-ups as possible in 60 s.
2.11.3. Standing balance
Postural balance was assessed with the stork balance test. While
in the standing position participants were instructed to balance on
the dominant leg with the heel lifted off the ground and the nondominant knee ﬂexed to 90° with the foot placed gently against the
inside of the dominant knee. Hands were placed on the hips at
the level of the iliac crests. The trial ended when the heel of the dominant leg touched the ﬂoor, the hands came off of the hips, or the nondominant foot was removed from the dominant standing leg.
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Participants were provided three attempts and the best time was recorded for analysis.
2.11.4. Flexibility
Lower back and hamstring ﬂexibility were assessed with the sit and
reach test. This was administered using a standard sit and reach box (Lafayette Instrument Company, Lafayette, IN), following standard technique. The maximal distance reached of 3 trials was recorded.
2.11.5. 5 km cycle ergometer time trial
Subjects arrived to the laboratory for performance testing sessions
having consumed a standardized meal (PRISE, IsaLean bar; RISE, granola
bar) 1 h prior. Before the time trial began, seat and handle bar length,
height and tilt were adjusted according to each subject's preferences.
Each adjustment was recorded and used for the post test (week 13). Following a 5–7 min warm-up at 60% of heart rate reserve (HRR) on the
Velotron Dynaﬁt Pro cycle ergometer (Racermate, CompuTrainer 3D
Software, Version 1, Seattle, WA, USA) participants completed a 5 km
time trial (5 km TT) as fast as possible. Pedaling cadence and gear
ratio were selected freely by the participant during each ride (week 0
and 13). Subjects were permitted to drink water, if needed (ad libitum).
Total time to complete the time trial, mean and max watts were all recorded. HR and blood pressure were monitored every 5 min during
the time trial, immediately upon ﬁnishing, and 5 and 10 min after
completion.
2.11.6. Upper and lower body maximal strength
Measures of one repetition maximal strength (1RM) of the upper
and lower body were assessed via the bench (barbell) and leg press, respectively as previously described [20]. Test-retest intraclass correlation
(r) and coefﬁcient of variation (CV) in our laboratory with n = 15 is:
chest 1-RM and leg 1-RM r = 0.99, CV = 1.6% and r = 0.99, CV =
2.7%, respectively.
2.11.7. Upper and lower body maximal force and power
Following 1RM's of the bench and leg press, dynamic maximal force
and power of the upper and lower body were assessed with bench
throws (BT) and jump squats (JS), respectively using the Ballistic Measurement System (Innervations Inc., Muncie, IN) interfaced with a commercial smith rack. Prior to performing the tests participants were
provided instructions on how to perform the tests safely and with proper technique. During the familiarization process subjects performed 3–5
un-weighted practice trials for the BT and JS. For the JS, participants performed 3 consecutive repetitions with the barbell loaded to 30% of their
predetermined IRM for the leg press. Participants began the JS in the
standing position with feet slightly wider than hip width apart and
the loaded barbell across the upper trapezius muscles. When instructed,
they lowered into the squat position until 90° of knee ﬂexion was
achieved then jumped as high as possible and landed with bent knees.
Immediately upon landing, without pause, participants repeated the
same upward jumping movement for a total of three maximal JS's in
succession.
For the bench throws (BT), participants followed identical familiarization procedures as the JS by performing 3–5 un-weighted practice trials lying supine on a bench with hands positioned on the barbell slightly
wider than shoulder width apart and arms fully extended. The bar was
then loaded with 20% of the 1 RM of the bench press. To initiate the BT's,
subjects lowered the barbell to the chest just above the distal end of the
sternum and were instructed to explosively push and then release the
barbell with the intent to project the barbell as high as possible. Participants caught the bar on its descent and immediately, without pause,
initiated another maximal BT until 3 successive repetitions were completed. Throughout both the JS and BT tests, spotters were present on
both sides of the barbell to provide verbal encouragement and ensure
safety of the participants. Peak power (watts) was taken as an average
of the three repetitions.
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2.12. Statistical analysis
Statistical analysis was performed using SPSS software (Ver. 23;
IBM). A 2 × 2 repeated measures ANOVA was performed to assess for interactions between groups (RISE vs. PRISE) in response to training and
to determine main effects of time (pre vs. post) and group. Post hoc
comparisons (Tukey's HSD) were performed if there was an interaction
with the addition of between-group independent samples t-tests at the
pre and post time points. One-tailed tests were utilized for this study
based upon our hypotheses and previous investigation showing improved body composition metrics following PRISE training [2] and the
signiﬁcance was set at p b 0.05. All values are reported as means ± SE
unless stated otherwise.
3. Results
3.1. Participant characteristics
The participant characteristics are presented in Table 1. Prior to the
intervention, all variables in each outcome domain (physical performance, cardiovascular health, body composition, diet, and metabolic
proﬁle) were not different between groups, with the exception of
basal growth hormone levels which were lower in RISE. Any participants who were unavailable for post-testing or non-compliant to the
diet and/or exercise routine were excluded from analysis, resulting in
an adherence rate N70% for both the nutrition and exercise components.
3.2. Muscular ﬁtness and exercise performance
By design, each of the ﬁtness and performance outcomes was improved following the interventions. Speciﬁcally, core (abdominal situps) and upper body muscular endurance (push-ups) were improved
(training effect, p b 0.01, Fig. 2A, B) but no group differences were
found (interaction, p N 0.05). Upper and lower body maximal strength,
assessed via 1RM bench press and leg press, respectively, were signiﬁcantly improved (p b 0.01, Fig. 2C, D), and upper body maximal strength
was improved to a signiﬁcantly greater extent in the PRISE group (interaction, p b 0.01, Fig. 2C). Likewise, upper (bench throws) and lower
(squat jumps) body muscular power were signiﬁcantly improved as a
result of the training (p b 0.05, Fig. 2E, F); however, lower body power
increased to a greater extent in the PRISE group (interaction, p b 0.05,
Fig. 2F).
Flexibility, as assessed by the sit reach test, was signiﬁcantly
(p b 0.05) improved following the intervention (Fig. 2G), though the
PRISE group increased ﬂexibility to a greater extent (interaction,
p b 0.05). Balance, assessed with the stork stand test, was unchanged
following the intervention and no differences were found between

Table 1
Baseline subject characteristics (N = 20).

Age (year)
Height (cm)
Weight (kg)
Body mass index (kg/m2)
Systolic blood pressure (mm Hg)
Diastolic blood pressure (mm Hg)
Pulse pressure (mm Hg)
Heart rate (beats/min)
Total cholesterol (mg/dl)
HDL cholesterol (mg/dl)
LDL cholesterol (mg/dl)
Triglycerides (mg/dl)
Glucose (mg/dl)

RISE (n = 9)

PRISE (n = 11)

45 ± 9
179 ± 7
81 ± 11
25 ± 2
119 ± 5
75 ± 6
44 ± 9
54 ± 6
176 ± 18
45 ± 10
106 ± 15
125 ± 37
81 ± 6

45 ± 6
179 ± 10
83 ± 14
26 ± 3
119 ± 10
75 ± 7
44 ± 9
57 ± 6
173 ± 28
55 ± 19
106 ± 25
82 ± 43
83 ± 9

RISE, normal protein (5–6 meals/day @ 1.0 g/kg BW/day) and RISE training; PRISE, protein-pacing (5–6 meals/day @ 2.0 g/kg BW/day) and RISE training; HDL, high density lipoprotein; LDL, low density lipoprotein. Data are means ± standard deviation.

groups (data not shown). Lastly, aerobic power, as assessed by time to
complete a 5 km cycling time trial was signiﬁcantly (p b 0.05) improved
following the training, with the PRISE group exhibiting a greater improvement (p b 0.05) (Fig. 2H).
3.3. Cardiovascular health
Systolic blood pressure (RISE: 119 ± 2 vs. 112 ± 3 mm Hg; PRISE:
121 ± 3 vs. 109 ± 3 mm Hg, pre- vs. post-intervention, respectively)
were signiﬁcantly improved following the exercise intervention
(p b 0.05), though no group differences were found (p N 0.05). However,
diastolic blood pressures were unchanged in response to the training
protocol (RISE: 75 ± 2 vs. 74 ± 2 mm Hg; PRISE: 75 ± 2 vs. 73 ± 2
mm Hg, pre- vs. post-intervention, respectively), and no differences
were observed between groups (p N 0.05). Resting heart rate was significantly reduced by the exercise intervention (RISE: 54 ± 2 vs. 51 ± 2
beats/min; PRISE: 57 ± 2 vs. 55 ± 2 beats/min, pre- vs. postintervention, respectively, training effect p b 0.05).
Augmentation index was signiﬁcantly improved following the training (p b 0.05) in both the brachial artery (RISE: −6 ± 11 vs. −17 ± 8%;
PRISE: −16 ± 10 vs. −20 ± 8%, pre- vs. post-intervention, respectively), and the aorta (RISE: 35 ± 6 vs. 29 ± 4%; PRISE: 30 ± 5 vs. 27 ± 4%,
pre- vs. post-intervention, respectively), but no differences were found
between groups (interaction, p N 0.05). Aortic pulse wave velocity and
return time were not signiﬁcantly impacted by the intervention in either group (p N 0.05). Assessment of circulating C-reactive protein,
was unaffected by training in either group (RISE: 0.41 ± 0.29 vs.
0.70 ± 0.39 μg/ml; PRISE: 0.70 ± 0.37 vs. 0.38 ± 0.22 μg/ml, p N 0.05,
pre- vs. post-intervention, respectively), and no differences were
found between groups.

3.4. Body composition
Body composition was signiﬁcantly improved in both groups following the training protocol, though no interactions were observed between groups. Independent of changes in body weight, signiﬁcant
improvements were observed in body composition (% body fat,
Table 2). Speciﬁcally, signiﬁcant reductions in total body, abdominal
and hip fat were observed following the intervention in both groups
(Table 2).

3.5. Diet, satiety, and hunger
At baseline, all participants met recommended daily intakes and
were not different between groups (Table 3). By design, the PRISE
group consumed signiﬁcantly more protein in absolute (grams) and relative (grams/kg body weight) terms (interaction, p b 0.05). Both RISE
and PRISE groups exhibited a reduction in the self-reported VAS question “How hungry do you feel right now?” (training effect, p b 0.05).
All other dietary factors remained constant across the intervention
and were similar between groups (Table 3).

3.6. Metabolic proﬁle
The exercise training protocol had no effect on resting metabolic rate
(p N 0.05), with no group effect (Table 4). However, RER and carbohydrate utilization (%) were reduced (p b 0.05) while fat utilization (%)
was increased in response to training (p b 0.05), but no differences
were found between groups. High density cholesterol levels were increased in both groups (p b 0.05) in response to training (Table 4),
though no group differences were evident. Accordingly, the total cholesterol/HDL ratio was also signiﬁcantly improved with training (p b 0.05),
though again no group differences were found (p N 0.05).
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Fig. 2. Exercise performance parameters at baseline (pre) and following 12 weeks (post) between RISE and PRISE. Abdominal strength and endurance (Panel A); upper body strength and
endurance (Panel B); upper and lower body maximal strength (Panels C and D); upper and lower body peak power (Panels E and F); endurance exercise (5 km cycling time trial)
performance and lower body ﬂexibility (Panels G and H). *p b 0.05 pre vs. post training, #p b 0.05 group difference in training response. RISE, normal protein + RISE training; PRISE,
protein-pacing + RISE training. Mean ± SE.

3.7. Growth hormone, brain derived neurotrophic factor, and IGF-1
At baseline, the RISE group had signiﬁcantly lower basal growth hormone (Fig. 3A), but basal levels of BDNF and IGF-1 were not different between groups (Fig. 3B and C). In terms of the GH response, the RISE
group exhibited a signiﬁcant increase, and the PRISE group had a tendency for increase basal GH levels (p = 0.10). BDNF levels tended to decline in response to the intervention, but did not approach signiﬁcance
(p = 0.48). In the RISE group IGF-1 exhibited a non-signiﬁcant decline
(126.9 ± 13.8 vs. 116.9 ± 9.3 ng/ml; p N 0.05), whereas, the PRISE

group had a signiﬁcant (98.6 ± 7.8 vs. 110.5 ± 8.3 ng/ml; p b 0.05) increase in IGF-1 (Fig. 3C), however, the interaction did not reach signiﬁcance (p = 0.09).
4. Discussion
The aim of this study was to determine the effect of a 12 week multimodal RISE training program (resistance, interval, stretch and endurance) with a normal protein intake (RISE, 5–6 meals/day @ 1.0 g/kg
BW/day) or in combination with a protein-pacing (P) diet (PRISE, 5–6
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Table 2
Changes in body composition pre- and post-intervention.

Body weight (kg)
Body fat (%)
Fat mass (kg)
Fat free mass (kg)
Lean body mass (kg)
Abdominal fat (%)
Hip fat (%)

RISE
PRISE
RISE
PRISE
RISE
PRISE
RISE
PRISE
RISE
PRISE
RISE
PRISE
RISE
PRISE

Table 4
Metabolic proﬁle pre- and post-intervention.

Pre

Post

81 ± 11
83 ± 14
23.0 ± 6.0
23.8 ± 6.5
17.9 ± 5.6
19.8 ± 5.4
62.0 ± 7.7
63.6 ± 7.0
58.8 ± 7.4
60.5 ± 6.6
26.8 ± 9.0
28.3 ± 12.5
21.5 ± 5.6
23.8 ± 5.7

79 ± 10
83 ± 14
22.1 ± 5.9a
22.6 ± 6.4a
17.2 ± 5.6a
18.6 ± 8.0a
62.4 ± 7.6
64.3 ± 7.0
59.2 ± 7.3
61.1 ± 6.6
25.4 ± 10.0a
26.3 ± 12.3a
20.2 ± 5.4a
22.0 ± 5.3a

RISE, normal protein (5–6 meals/day @ 1.0 g/kg BW/day) and RISE training; PRISE, protein-pacing (5–6 meals/day @ 2.0 g/kg BW/day) and RISE training; data are means ± standard deviation.
a
Denotes signiﬁcant effect of intervention (pre vs. post).

Resting metabolic rate (kcal/day)
Respiratory exchange ratio
CHOox (%)
FATox (%)
Fasting blood glucose (mg/dl)
Insulin (uU/ml)
Total cholesterol (mg/dl)
HDL cholesterol (mg/dl)
LDL cholesterol (mg/dl)
Total cholesterol/HDL
Triglycerides (mg/dl)

meals/day @ 2.0 g/kg BW/day) on exercise performance, growth hormone (GH), insulin-like growth factor-1 (IGF-1), brain-derived neurotrophic factor (BDNF) responses, cardiovascular health, body
composition, and metabolism in healthy active men. The main ﬁndings
of the current study are that the RISE protocol: 1) elicited signiﬁcant improvements in performance (5 km TT, upper and lower body maximal
strength and peak power, ﬂexibility), and several of these improvements were enhanced in the PRISE group, speciﬁcally upper body maximal strength, lower body muscular power, ﬂexibility and aerobic
power; 2) improved cardiovascular outcomes (systolic blood pressure
as well as both aortic and brachial augmentation index), shifted substrate utilization to reduce carbohydrate and increase fat oxidation, improved body composition (%fat, total body, abdominal, and hip fat loss,
and increased lean body mass) were improved with training, and

Table 3
Diet, satiety, and hunger ratings pre- and post-intervention.

Caloric intake (kcal/day)
Fat intake (g/day)
Carbohydrate intake (g/day)
Protein intake (g/day)
Protein intake (g/kg BW/day)
Cholesterol intake (mg/day)
Sodium intake (mg/day)
Fiber intake (g/day)
How hungry are you feeling (0−100)
How full do you feel (0–100)
How much food could you eat (0–100)
What is your desire to eat (0–100)

RISE
PRISE
RISE
PRISE
RISE
PRISE
RISE
PRISE
RISE
PRISE
RISE
PRISE
RISE
PRISE
RISE
PRISE
RISE
PRISE
RISE
PRISE
RISE
PRISE
RISE
PRISE

Pre

Post

1970 ± 430
2148 ± 435
66 ± 25
77 ± 39
206 ± 23
230 ± 38
116 ± 59
119 ± 36
1.5 ± 0.6
1.4 ± 0.4
406 ± 424
463 ± 300
2356 ± 917
2608 ± 1494
24 ± 7
33 ± 14
46 ± 21
47 ± 25
33 ± 18
27 ± 23
55 ± 14
53 ± 22
46 ± 22
46 ± 28

1898 ± 294
2286 ± 213
59 ± 28
76 ± 10
217 ± 19
234 ± 33
90 ± 18
182 ± 34a
1.1 ± 0.1
2.2 ± 0.7a
221 ± 64
604 ± 237a
2221 ± 1275
2505 ± 403
23 ± 10
30 ± 7
32 ± 18b
42 ± 27b
42 ± 16
24 ± 12
53 ± 8
55 ± 29
37 ± 20
45 ± 28

RISE, normal protein (5–6 meals/day @ 1.0 g/kg BW/day) and RISE training; PRISE, protein-pacing (5–6 meals/day @ 2.0 g/kg BW/day) and RISE training; data are means ± standard deviation.
a
Denotes signiﬁcant interaction of group (RISE; 1 g/kg of body weight) vs. (PRISE;
2 g/kg of body weight).
b
Denotes signiﬁcant effect of intervention.

RISE
PRISE
RISE
PRISE
RISE
PRISE
RISE
PRISE
RISE
PRISE
RISE
PRISE
RISE
PRISE
RISE
PRISE
RISE
PRISE
RISE
PRISE
RISE
PRISE

Pre

Post

1776 ± 280
1843 ± 280
0.84 ± 0.07
0.83 ± 0.04
47 ± 24
43 ± 14
53 ± 24
57 ± 14
81 ± 6
83 ± 9
2.7 ± 0.5
2.8 ± 0.7
176 ± 18
173 ± 28
45 ± 10
51 ± 15
106 ± 15
114 ± 27
4.0 ± 0.7
3.5 ± 1.0
125 ± 37
92 ± 46

1804 ± 243
1864 ± 380
0.81 ± 0.04a
0.80 ± 0.03a
38 ± 16a
33 ± 11a
62 ± 16a
67 ± 12a
81 ± 8
86 ± 10
2.5 ± 0.3
2.9 ± 0.8
180 ± 27
171 ± 27
49 ± 12a
53 ± 13a
111 ± 22
109 ± 24
3.8 ± 0.8a
3.3 ± 1.0a
109 ± 42
90 ± 60

RISE, normal protein (5–6 meals/day @ 1.0 g/kg BW/day) and RISE training; PRISE, protein-pacing (5–6 meals/day @ 2.0 g/kg BW/day) and RISE training; CHOox, relative contribution of carbohydrate to energy expenditure; FATox, relative contribution of fat to energy
expenditure; HDL, high density lipoprotein; LDL, low density lipoprotein. Data are
means ± standard deviation.
a
Denotes signiﬁcant effect of intervention (pre vs. post).

decreased sensations of hunger; however, there were no group differences in these responses; and 3) the RISE training increased GH levels,
which was not as pronounced in the PRISE group, likely, in part, due
to different baseline levels, while BDNF was unchanged in both groups,
and IGF-1 was increased in the PRISE group only.
In summary, we provide novel insight into the impact of a multimodal (RISE) exercise training protocol which improves multiple aspects of performance (muscle strength, power, ﬂexibility, and aerobic
power) in healthy active males, which might be, in part, due to increased GH levels. These beneﬁts can be augmented, through adding a
protein-pacing dietary approach (5–6 meals/day @ 2.0 g/kg BW/day)
which acts synergistically to enhance the increases in upper body muscle strength, lower body power, ﬂexibility and aerobic power performance associated with multi-modal exercise training, which might
occur independent of changes in circulating GH, IGF-1, or BDNF.

4.1. Fitness, and performance outcomes
Our previous investigation using the multimodal RISE training protocol in overweight/obese men and women, targeted and observed improvements in body composition and cardiometabolic risk reduction
[2]. However, it remained unanswered whether RISE may enhance
physical performance outcomes. To this aim, we recently determined
the RISE protocol does, in fact, improve performance, in healthy exercise
trained women [3]. Previous work on concurrent training, where
strength and endurance training are combined, has revealed that either
endurance capacity [21] or muscle strength [22], may be compromised,
which might be due to competing signals for adaptation or perhaps the
decreased emphasis on training for either or possibly due to
overtraining. Herein the current study, we observed signiﬁcant improvements in endurance performance (5 km TT), muscular strength
(1RM), power (jump squat or bench throw), ﬂexibility (sit and reach),
and muscle endurance (maximum # of pushups and sit-ups), which is
in agreement with our prior work [3]. Thus, in both men and women,
we contend that multimodal training paradigms are not antithetical to
ﬁtness-related gains in performance and might reduce over-training
or “burn out”.
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induced improvement in performance outcomes [6,8,9]. Further, our
protein intake per meal in the current study was 0.41 g/kg/meal
which has been shown to optimally stimulate muscle protein synthesis
[18] and may be partly responsible for the enhanced performance outcomes in the PRISE group. The ﬁnding of increased aerobic power
(5 km TT) in PRISE men corroborates previous data showing a high dietary protein (whey) intake increases muscle strength and endurance,
even during intense training [8].

4.2. Cardiovascular health
Acute ingestion of milk and/or whey proteins alone has been demonstrated to improve vascular health or factors contributing to CVD
risk [26–28]. In the current study, we demonstrate that 12 weeks of a
multi-mode training program targeting multiple aspects of ﬁtness
(muscular endurance, strength and power, ﬂexibility, aerobic power,
and balance), results in signiﬁcant reductions in systolic blood pressure
(Δ10 vs. Δ6 mm Hg, PRISE vs. RISE). Such changes are known to significantly reduce risk of coronary heart disease events and stroke, by approximately 25% [29]. Similarly, the observed improvement in
augmentation index (AIx) also translates into a reduction in CV risk
[30]. Taken together, these ﬁndings suggest that the multimodal RISE
training improves vascular health, independent of protein intake.
Although previous investigations report resistance training may elevate vascular stiffness [31], the current study, in agreement with recent
work in women [3], shows that a multimodal training protocol reduces
peripheral and central augmentation index (along with reduced systolic
blood pressure), suggestive of a training-induced reduction in peripheral resistance. This is particularly relevant in light of the growing emphasis, via guidelines and popularity, on multi-modal exercise paradigms
and how each ﬁtness component may inﬂuence vascular health.

4.3. Body composition
Similarly to our previous ﬁnding with exercise trained women [3],
both groups experienced signiﬁcant improvement in body composition,
highlighting the independent effect of the RISE exercise protocol in
stimulating fat loss and increasing lean body mass regardless of dietary
protein intake. However, this ﬁnding also suggests that further body
composition changes may be delayed compared to physical performance changes that respond most favorably to the higher protein per
meal regimen in PRISE (Supplemental Table 1). It is plausible that a
higher amount of protein may be needed to elicit enhanced body composition changes during PRISE training in exercise trained individuals.
This contention is supported by others showing protein intakes as
high as 3.4 g/kg body weight/day in combination with heavy resistance
training induced additional reductions in fat mass [32]. Whether this
level of protein intake is necessary beyond the current 2.0 g/kg BW/
day warrants further investigation.

4.4. Satiation and hunger ratings and dietary intake
Fig. 3. Blood growth factor parameters at baseline (pre) and following 12 weeks (post)
between RISE and PRISE. Growth hormone (Panel A); brain derived neurotrophic factor
(BDNF) (Panel B), and insulin-like growth factor-1 (Panel C). *p b 0.05 pre vs. post
training, #p b 0.05 group difference at baseline. RISE, normal protein + RISE training;
PRISE, protein-pacing + RISE training. Mean ± SE.

Given the heightened emphasis on increasing dietary protein among
athletes and the general population [23–25], it's important to evaluate
its efﬁcacy within the context of a comprehensive exercise training intervention. Indeed, our data suggests a P diet augments the training-

In the current study, self-reported feelings of hunger (“how hungry
are you feeling right now?”) were signiﬁcantly lower following the
12 week intervention in both groups (Table 3). There is limited evidence
supporting the hunger suppressing effects of exercise training [33].
Most of the available evidence showing a reduction in hunger ratings
is due to increased dietary protein [34–36]. In the current study, protein
intake was intentionally different between groups and matched the
protein goals for each group (RISE, 1.0 g/kg BW/day; PRISE, 2.0 g/kg
BW/day) (Table 3). Therefore, the likely explanation for a similar reduction in hunger ratings may be attributed to the RISE exercise intervention and not necessarily the protein intake.
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4.5. Metabolic proﬁle
Increased dietary protein intake, beyond the recommended daily intake, has been suggested to acutely [27] and/or chronically improve cardiometabolic proﬁle [28]. In agreement, the PRISE protocol has been
demonstrated to improve metabolic proﬁle in overweight/obese [2],
and recently in active women [3]. However, the magnitude and degree
of protein pacing (g/kg BW/day) as well as the population studied
(healthy vs. disease) likely play a role in whether PRISE alters metabolic
proﬁle, and the extent to which it is improved. The current study demonstrated a shift in resting substrate utilization, speciﬁcally RER and
CHO oxidation (% of total energy expenditure, EE) were decreased,
while fat oxidation (% of total EE) was increased (Table 4), which
might have contributed to the reduction in total body, abdominal, and
hip fat. Additionally, the increase in HDL cholesterol, and corresponding
improvement in TC/HDL ratio (Table 4), is in agreement with previous
researchers who have demonstrated that exercise training improves
lipid proﬁle in response to exercise training [37,38]. However, there
may be a sex speciﬁc lipid proﬁle response to the RISE training as
women do not seem to exhibit any change in lipid proﬁle [3].
4.6. Growth hormone, brain derived neurotrophic factor, and insulin-like
growth factor-1

intervention. Additionally, the limitation of measuring circulating anabolic hormones must also be acknowledged, in that alterations in the receptor availability and/or post-receptor signaling could play a role
independent of blood levels of GH, BDNF, or IGF-1. Finally, the additive
effect of protein pacing with RISE training on ﬁtness-related outcomes
could be wholly independent of hormonal signaling and rely more
upon a simple improvement in nitrogen balance.
5. Conclusion
In conclusion, the RISE training protocol improved multiple aspects
of exercise performance, cardiovascular health, shifted metabolism towards increased fat utilization, and improved body composition. Inclusion of protein-pacing (P, 2.0 g/kg BW/day) in conjunction with RISE
(PRISE) enhanced the training-induced adaptations in upper body
strength and lower body muscle power, and aerobic power performance in exercise trained men. This study provides evidence that the
RISE exercise training is capable of eliciting further adaptations in
those currently performing exercise training, and that increasing dietary
protein intake beyond the recommended daily intake may augment the
training-induced adaptations to multimodal exercise training programs.
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Appendix A
[13]
Table A1
Sample menus from the RISE and PRISE nutritional intervention diet plans during the
12 week intervention. Menus were isocaloric and similar in meal timing.
RISE (1.0 g/kg BW/day)
Breakfast

Steel cut oats, eggs, honey,
nut/seed butter, fruit, caffeine
beverage, One-A-Day
Multivitamins®; 15 g protein;
30 g carbohydrate; 15 g fat
Mid-morning
Nature Valley Protein Chewy
snack
Bars®
12 g protein, 14 g carbohydrate,
12 g fat
Lunch
Whole grain pita,
tuna/turkey/chicken, baked
chips, fresh fruit; 20 g protein;
30 g carbohydrate; 15 g fat
Mid-Afternoon Nature Valley Sweet and Salty
snack
Nut Granola Bars®, Horizon
Organic Milk®; 12 g protein,
42 g carbohydrate, 10 g fat
Dinner
Fish/poultry/beef, whole grain
rice/pasta or legumes, fresh
vegetables, dried fruit, olive oil,
water; 20 g protein; 30 g
carbohydrate; 15 g fat
Evening snack Fresh fruit, nuts; 2–3 g protein;
20 g carbohydrate; 9 g fat
Exercise days*

Gatorade G2®, electrolyte
beverage

PRISE (2.0 g/kg BW/day)
Eggs/egg whites, blueberries,
coconut butter/milk, e+®
caffeine beverage, Ageless
Essentials®; 25 g protein; 15 g
carbohydrate; 15 g fat
IsaPro®, fresh fruit, 30 g
protein; 3 g carbohydrate;
1.5 g fat
IsaLean Pro®; 36 g protein;
21 g carbohydrate; 6 g fat

[14]

[15]

[16]

[17]

[18]
[19]

IsaLean Bars®, 1/2 cup of
Greek yogurt or fruit
25 g protein; 30 g
carbohydrate; 5 g fat
Fish/poultry/beef, fresh
vegetables, chopped nuts,
dried fruit, olive oil, milk; 25 g
protein; 20 g carbohydrate;
15 g fat
Greek yogurt, fruit, Ionix
Supreme®; 20 g protein; 20 g
carbohydrate; 5 g fat;
Replenish®, electrolyte
beverage

RISE, protein based on 1.0 g/kg BW/day for an 80 kg man; PRISE, protein based on 2.0 g/kg
BW/day for an 80 kg man. Meals were consumed ~3 h apart throughout the day.

[20]

[21]

[22]

[23]

[24]

[25]
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